Clinical classifiers of COVID-19 infection from novel ultra-high-throughput proteomics

Christoph B. Messner; Vadim Demichev; Daniel Wendisch; Laura Michalick; Matthew White; Anja Freiwald; Kathrin Textoris-Taube; Spyros I. Vernardis; Anna-Sophia Egger; Marco Kreidl; Daniela Ludwig; Christiane Kilian; Federica Agostini; Aleksej Zelezniak; Charlotte Thibeault; Moritz Pfeiffer; Stefan Hippenstiel; Andreas Hocke; Christof von Kalle; Archie Campbell; Caroline Hayward; David J. Porteous; Riccardo E. Marioni; Claudia Langenberg; Kathryn S. Lilley; Wolfgang M. Kuebler; Michael Muelleder; Christian Drosten; Martin Witzenrath; Florian Kurth; Leif Erik Sander; Markus Ralser.
Preprint en Inglés | PREPRINT-MEDRXIV | ID: ppmedrxiv-20081810

Documentos relacionados

  1. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection.
  2. Increasing Proteome Depth While Maintaining Quantitative Precision in Short-Gradient Data-Independent Acquisition Proteomics.
  3. Deciphering the omicron variant: integrated omics analysis reveals critical biomarkers and pathophysiological pathways.
  4. Proteomics applications in biomarker discovery and pathogenesis for abdominal aortic aneurysm.
  5. Standardized Workflow for Precise Mid- and High-Throughput Proteomics of Blood Biofluids.
  6. High-throughput, in-depth and estimated absolute quantification of plasma proteome using data-independent acquisition/mass spectrometry ("HIAP-DIA").
  7. Advances in quantitative high-throughput phosphoproteomics with sample multiplexing.
  8. Automated proteomic sample preparation: The key component for high throughput and quantitative mass spectrometry analysis.
  9. Rapid Sample Preparation Workflow for Serum Sample Analysis with Different Mass Spectrometry Acquisition Strategies.
  10. A review of the current state of single-cell proteomics and future perspective.